These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25137004)
21. [Crystalloid versus colloid. A never ending story?]. Dieterich HJ Anaesthesist; 2001 Jun; 50(6):432-5. PubMed ID: 11463051 [No Abstract] [Full Text] [Related]
22. Why hydroxyethyl starch solutions should NOT be banned from the operating room. De Hert S; De Baerdemaeker L Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553 [TBL] [Abstract][Full Text] [Related]
23. Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions. Davidson IJ Eur J Anaesthesiol; 2007 Oct; 24(10):892-3. PubMed ID: 17977101 [No Abstract] [Full Text] [Related]
24. Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: a meta-analysis. Saw MM; Chandler B; Ho KM Anaesth Intensive Care; 2012 Jan; 40(1):17-32. PubMed ID: 22313061 [TBL] [Abstract][Full Text] [Related]
25. Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study. Gurbuz HA; Durukan AB; Salman N; Tavlasoglu M; Durukan E; Ucar Hİ; Yorgancioglu C J Cardiothorac Surg; 2013 Apr; 8():71. PubMed ID: 23566712 [TBL] [Abstract][Full Text] [Related]
26. Is the literature inconclusive about the harm from HES? Yes. Ertmer C; Annane D; Van Der Linden P Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102 [No Abstract] [Full Text] [Related]
27. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Perel P; Roberts I Cochrane Database Syst Rev; 2012 Jun; (6):CD000567. PubMed ID: 22696320 [TBL] [Abstract][Full Text] [Related]
28. Complications of hydroxyethyl starch in paediatric patients. Veldman A Eur J Anaesthesiol; 2010 Jan; 27(1):86-7. PubMed ID: 20050131 [No Abstract] [Full Text] [Related]
32. Concerns over use of hydroxyethyl starch solutions. Hartog CS; Natanson C; Sun J; Klein HG; Reinhart K BMJ; 2014 Nov; 349():g5981. PubMed ID: 25385352 [TBL] [Abstract][Full Text] [Related]
33. Quantity may be more important than type of intravenous fluid. Silversides JA; Ferguson AJ Crit Care Med; 2012 Feb; 40(2):709-10; author reply 710-1. PubMed ID: 22249072 [No Abstract] [Full Text] [Related]
34. Colloids in Cardiac Surgery-Friend or Foe? Ryhammer PK; Tang M; Hoffmann-Petersen J; Leonaviciute D; Greisen J; Storebjerg Gissel M; Jakobsen CJ J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1639-1648. PubMed ID: 28372955 [TBL] [Abstract][Full Text] [Related]
35. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337 [TBL] [Abstract][Full Text] [Related]
36. Evidence-based emergency medicine. Hypertonic versus isotonic crystalloid for fluid resuscitation in critically ill patients. Brown MD Ann Emerg Med; 2002 Jul; 40(1):113-4. PubMed ID: 12085082 [No Abstract] [Full Text] [Related]
38. Crystalloid versus colloid versus colloid: all colloids are not created equal. Traylor RJ; Pearl RG Anesth Analg; 1996 Aug; 83(2):209-12. PubMed ID: 8694293 [No Abstract] [Full Text] [Related]
39. Data too important to share: do those who control the data control the message? Doshi P BMJ; 2016 Mar; 352():i1027. PubMed ID: 26936297 [No Abstract] [Full Text] [Related]
40. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery. Haynes GR J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]